Clinical Trials Browser

Phase 3 × Terminated × tislelizumab × Clear all

NCT04866017 2024-10-31

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Phase 3 Terminated

63 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT03745222 2020-07-15

RATIONALE001

Phase 3 Terminated

1 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung